Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes QTLs Strains Markers Genome Information Ontologies Cell Lines References FTP Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Variant Visualizer Multi-Ontology Enrichment (MOET) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) RatMine GViewer (Genome Viewer) Overgo Probe Designer ACP Haplotyper Genome Scanner
Aging & Age-Related Disease Cancer Cardiovascular Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Genetic Models PhenoMiner (Quantitative Phenotypes) Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Phenotypes GERRC (Gene Editing Rat Resource Center) Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Poster Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Gene: Snx25 (sorting nexin 25) Rattus norvegicus
Analyze
Symbol: Snx25
Name: sorting nexin 25
Description: Predicted to have type I transforming growth factor beta receptor binding activity. Predicted to be involved in negative regulation of pathway-restricted SMAD protein phosphorylation; negative regulation of transforming growth factor beta receptor signaling pathway; and receptor catabolic process. Predicted to localize to the endosome and intracellular membrane-bounded organelle. Orthologous to human SNX25 (sorting nexin 25); INTERACTS WITH (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE; 2,3,7,8-tetrachlorodibenzodioxine; 2,4-dinitrotoluene.
Type: protein-coding
RefSeq Status: MODEL
Also known as: LOC306471; sorting nexin-25
Orthologs:
Homo sapiens (human) : SNX25 (sorting nexin 25)  HGNC  Alliance
Mus musculus (house mouse) : Snx25 (sorting nexin 25)  MGI  Alliance
Chinchilla lanigera (long-tailed chinchilla) : Snx25 (sorting nexin 25)
Pan paniscus (bonobo/pygmy chimpanzee) : SNX25 (sorting nexin 25)
Canis lupus familiaris (dog) : SNX25 (sorting nexin 25)
Ictidomys tridecemlineatus (thirteen-lined ground squirrel) : Snx25 (sorting nexin 25)
Sus scrofa (pig) : SNX25 (sorting nexin 25)
more info ...
Allele / Splice: Snx25Tn(sb-T2/Bart3)2.270Mcwi  
Genetic Models: F344-Snx25Tn(sb-T2/Bart3)2.270Mcwi
Latest Assembly: Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Rnor_6.01649,328,958 - 49,432,415 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_5.01649,051,539 - 49,159,381 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41649,415,658 - 49,518,663 (+)NCBIRGSC3.4rn4RGSC3.4
RGSC_v3.11649,415,438 - 49,518,714 (+)NCBI
Celera1644,133,781 - 44,236,984 (+)NCBICelera
Cytogenetic Map16q11NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model

Annotation    (Toggle Annotation Detail/Summary View)

Disease Annotations
Gene-Chemical Interaction Annotations
Gene Ontology Annotations
References - curated
References - uncurated
RGD Disease Portals

Genomics

Comparative Map Data
Position Markers
QTLs in Region (Rnor_6.0)
Genetic Models
miRNA Target Status

Sequence

Nucleotide Sequences
Protein Sequences
Transcriptome

Strain Variation

Strain Sequence Variants (Rnor 5.0)

Additional Information

External Database Links
Nomenclature History
  
More on Snx25
Alliance Gene
NCBI Gene
Ensembl Gene
JBrowse: rn5 rn6
NCBI Genome Data Viewer

RGD Object Information
RGD ID: 1310150
Created: 2005-01-12
Species: Rattus norvegicus
Last Modified: 2019-04-23
Status: ACTIVE



Contact Us |  About Us |  License CC BY 4.0 |  Legal Disclaimer |  © Medical College of Wisconsin
NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.